Levilimab (BCD-089) is a fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid.
Purity:
95.0%
CAS Number:
[2035008-70-7]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted